Bioactive Compounds and Natural Products
Bioactive compounds and natural products are chemical substances produced by living organisms — plants, fungi, microbes, and marine life — that exert measurable biological effects and have historically been a primary source of medicines. This area of pharmacognosy concerns how such compounds are discovered, isolated, characterised, and linked to biological activity, bridging natural-product chemistry with pharmacology.
Definition
Natural products are secondary metabolites synthesised by organisms that are not essential to primary metabolism; bioactive compounds are those that produce a specific, measurable biological response, and together they form the chemical foundation of much of pharmacognosy and natural-product drug discovery.
Scope
The area covers the major classes of secondary metabolites (alkaloids, terpenoids, phenolics, glycosides, and others), the workflow from bioactivity-guided isolation to structure elucidation, and the principal activity profiles studied in natural products: structure-activity relationships, bioassay-based screening, and antimicrobial, antioxidant, and anti-inflammatory effects. It is a reference and educational orientation, not clinical guidance.
Sub-topics
Core questions
- Which classes of natural compounds are most often biologically active, and why?
- How is a compound's structure connected to its biological activity?
- How are candidate bioactive compounds detected, isolated, and validated?
- What roles do antimicrobial, antioxidant, and anti-inflammatory activities play in natural-product research?
Key concepts
- Secondary metabolites
- Bioactivity-guided isolation
- Structure elucidation
- Chemical scaffolds and structural diversity
- Lead compound and drug discovery from nature
- Ethnopharmacological leads
Mechanisms
Organisms synthesise secondary metabolites — through pathways such as the shikimate, polyketide, mevalonate, and alkaloid routes — that often interact with biological macromolecules in other organisms, giving rise to pharmacological activity. Discovery typically proceeds by bioactivity-guided fractionation: a crude extract is tested in a bioassay, then separated into fractions that are re-tested, iterating until a pure active compound is isolated and its structure determined by spectroscopic methods. Natural products occupy a chemical space rich in stereochemistry and sp3 character that has repeatedly yielded clinically useful scaffolds.
Clinical relevance
A large share of approved small-molecule drugs are natural products or are derived from or inspired by them, so this area underpins much of pharmacology and pharmacognosy education. It describes how compounds become drug leads and how their activities are characterised; it is a reference orientation and not a basis for individual diagnostic or treatment decisions.
Evidence & guidelines
Evidence in this area is largely preclinical and chemical — isolation reports, bioassay data, and structure-activity analyses — with systematic surveys such as Newman and Cragg quantifying the contribution of natural products to the drug pipeline. Translation to clinical use follows the same regulatory pathways as other drug candidates.
History
Natural products have been the dominant source of medicines for most of recorded history, from plant-derived remedies to the isolation of morphine, quinine, and the antibiotics of the twentieth century. The modern field combines classical phytochemistry with chromatographic separation and spectroscopic structure determination, and surveys of the drug pipeline have repeatedly documented the enduring role of natural products even amid the rise of synthetic and combinatorial chemistry.
Debates
- Have natural products been displaced by synthetic and combinatorial chemistry in drug discovery?
- Despite a mid-career shift toward synthetic libraries, analyses of approved drugs show natural products and their derivatives remain a major and continuing source of new chemical entities, prompting renewed interest in natural-product-inspired discovery.
Key figures
- David J. Newman
- Gordon M. Cragg
- Jon Clardy
- Christopher Walsh
Related topics
Seminal works
- newman-cragg-2012
- cragg-newman-2005
- clardy-walsh-2004
Frequently asked questions
- What is the difference between a natural product and a bioactive compound?
- A natural product is any secondary metabolite made by an organism; a bioactive compound is one that produces a measurable biological effect. Many natural products are bioactive, which is why they are central to drug discovery, but not every natural product has notable activity.
- Why are natural products still important for drug discovery?
- They occupy a chemical space with structural diversity and three-dimensional complexity that synthetic libraries often lack, and surveys of approved drugs show that natural products and their derivatives continue to supply a large fraction of new medicines.